The authors identify SPI1 as a potential transcription factor regulating the hub genes but provide no mechanistic details of this regulatory relationship. Given SPI1's role in microglial activation and neuroinflammation, this regulatory circuit may be relevant to cerebrovascular disease and neurodegeneration.
Gap type: unexplained_observation
Source paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)
Circulating C1Q from atherosclerotic plaques crosses a compromised blood-brain barrier and primes microglial SPI1 expression, creating neuroinflammatory memory that predisposes to neurodegeneration. Anti-C1Q biologics could prevent this vascular-to-brain inflammatory transmission.
No AI visual card yet
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
8 citations8 with PMID8 mediumValidation: 0%5 supporting / 3 opposing
✓For(5)
5
3
(3)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
5
2
1
MECH 5CLIN 2GENE 1EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
A lymphocyte-microglia-astrocyte axis in chronic a…
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-09 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Based on the literature describing SPI1's role as a transcription factor regulating hub genes in atherosclerosis and neuroinflammation, I'll generate novel therapeutic hypotheses that bridge vascular and neurological pathology:
Description: SPI1 directly regulates C1Q expression in brain microglia, creating a feed-forward loop that amplifies neuroinflammation in cerebrovascular disease. Selective inhibition of SPI1 binding to C1Q promoter regions could break this pathological circuit while preservin
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
I'll provide a rigorous critique of each hypothesis based on the evidence presented and known biological principles. Let me evaluate these systematically:
Speculative Direct Regulation: No evidence provided that SPI1 directly binds C1Q promoter regions in brain microglia
Feed-Forward Loop Assumption: The proposed "feed-forward loop" mechanism lacks supporting data - C1Q doesn't necessarily regulate SPI1 expression
**Tissue C
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Now let me check for specific information about complement C1q therapies and look up more details about ANX005, which appears to be a C1q inhibitor in clinical development.
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
Based on the comprehensive debate between the Theorist, Skeptic, and Expert assessments, I'll synthesize the evidence and provide scored rankings for the seven SPI1-targeted therapeutic hypotheses.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.